Excellent event-free survival (EFS) in newly diagnosed high-risk (HR) medulloblastoma (MB) treated with craniospinal radiation (CSI) therapy followed by 4 cycles of high-dose chemotherapy and stem cell rescue: Results of a prospective multicenter trial (SJMB 96)

被引：0

作者：

Gaijar, A ^{[1
]}

Chintagumpala, M ^{[1
]}

Kellie, S ^{[1
]}

Ashley, D ^{[1
]}

Hassall, T ^{[1
]}

Wallace, D ^{[1
]}

Hale, G ^{[1
]}

Broniscer, A ^{[1
]}

Fouladi, M ^{[1
]}

Merchant, T ^{[1
]}

Krasin, M ^{[1
]}

Woo, S ^{[1
]}

Sexton, M ^{[1
]}

Ahem, V ^{[1
]}

Cheuk, R ^{[1
]}

Lau, C ^{[1
]}

Gilbertson, R ^{[1
]}

Kun, L ^{[1
]}

机构：

[1] St Jude Childrens Res Hosp, Div NeuroOncol, Dept Hematol Oncol, Memphis, TN 38105 USA

来源：

NEURO-ONCOLOGY | 2004年 / 6卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：455 / 455

页数：1

共 13 条

[1] Excellent event-free survival (EFS) in newly diagnosed patients with supratentorial primitive neurectodermal tumors (SPNET) treated with risk-adapted craniospinal (CSI) radiation (RT) therapy followed by 4 cycles of high-dose chemotherapy and stem cell rescue.
Chintagumpala, M
Ashley, D
Hassall, T
Wallace, D
Merchant, TE
Woo, S
Sexton, M
Cheuk, R
Gajjar, A
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 813S - 813S
[2] Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Gajjar, Amar
Chintagumpala, Murali
Ashley, David
Kellie, Stewart
Kun, Larry E.
Merchant, Thomas E.
Woo, Shaio
Wheeler, Greg
Ahern, Valerie
Krasin, Matthew J.
Fouladi, Maryam
Broniscer, Alberto
Krance, Robert
Hale, Gregory A.
Stewart, Clinton F.
Dauser, Robert
Sanford, Robert A.
Fuller, Christine
Lau, Ching
Boyett, James M.
Wallace, Dana
Gilbertson, Richard J.
LANCET ONCOLOGY, 2006, 7 (10): : 813 - 820
[3] Tumor histology is an important independent prognostic factor of event-free survival in average-risk and high-risk medulloblastoma: Results from a prospective collaborative trial (SJMB 96)
Gajjar, A.
Chintagumpala, M.
Ashley, D.
Broniscer, A.
Fouladi, M.
Wallace, D.
Merchant, T.
Kun, L.
Gilbertson, R.
Fuller, C.
NEURO-ONCOLOGY, 2007, 9 (02) : 192 - 192
[4] RISK-ADAPTED CRANIOSPINAL RADIOTHERAPY FOLLOWED BY HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL RESCUE IN CHILDREN WITH LARGE CELL/ANAPLASTIC MEDULLOBLASTOMA: RESULTS FROM ST. JUDE MEDULLOBLASTOMA 96 (SJMB96) AND ST. JUDE MEDULLOBLASTOMA 03 (SJMB03)
Wright, K. D.
Chintagumpala, M.
Hassall, T.
Ashley, D. M.
Bouffet, E.
Kellie, S. J.
Gururangan, S.
Cohn, R.
Fisher, M.
Broniscer, A.
Qaddoumi, I.
Morris, E. B.
Armstrong, G.
Merchant, T. E.
Panandiker, A. Pai
Ellison, D. W.
Lesh, S.
Wallace, D.
Gajjar, A.
NEURO-ONCOLOGY, 2010, 12 (06) : II5 - II6
[5] Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblostoma-96): Long-term results from a prospective, multicentre trial (vol 7, pg 813, 2006)
Gajjar, A.
Chintagumpala, M.
Ashley, D.
LANCET ONCOLOGY, 2006, 7 (10): : 797 - 797
[6] TANDEM HIGH-DOSE CHEMOTHERAPY WITH STEM CELL RESCUE FOLLOWED BY RISK-ADAPTED RADIATION IN CHILDREN WITH HIGH-RISK CEREBRAL PRIMITIVE NEUROECTODERMAL TUMOR: RESULTS OF THE PROSPECTIVE SFCE-TRIAL PNET HR+5
Dufour, Christelle
Delisle, Marie-Bernadette
Geoffray, Anne
Laplanche, Agnes
Frappaz, Didier
Icher, Celine
Bertozzi, Anne-Isabelle
Leblond, Pierre
Doz, Francois
Andre, Nicolas
Schneider, Pascale
De Carli, Emilie
Berger, Claire
Lejars, Odile
Chastagner, Pascal
Soler, Christine
Entz-Werle, Natacha
Valteau-Couanet, Dominique
NEURO-ONCOLOGY, 2014, 16 : 10 - 10
[7] Tandem high-dose chemotherapy with stem cell rescue followed by risk-adapted radiation in children with high-risk cerebral primitive neuroectodermal tumor: Results of the prospective SFCE-trial PNET HR+5.
Dufour, Christelle
Delisle, Marie-Bernadette
Geoffray, Anne
Laplanche, Agnes
Frappaz, Didier
Icher, Celine
Bertozzi, Anne-Isabelle
Leblond, Pierre
Doz, Francois P.
Andre, Nicolas
Schneider, Pascale
De Carli, Emilie
Berger, Claire
Lejars, Odile
Chastagner, Pascal B.
Pagnier, Anne
Soler, Christine
Entz-Werle, Natacha
Valteau-Couanet, Dominique
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[8] Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: Results of a collaborative study
Strother, D
Ashley, D
Kellie, SJ
Patel, A
Jones-Wallace, D
Thompson, S
Heideman, R
Benaim, E
Krance, R
Bowman, L
Gajjar, A
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) : 2696 - 2704
[9] TANDEM HIGH-DOSE CHEMOTHERAPY WITH STEM CELL RESCUE FOLLOWED BY RISK-ADAPTED RADIATION IN CHILDREN WITH HIGH-RISK CEREBRAL PRIMITIVE NEUROECTODERMAL TUMOR: RESULTS OF THE SFCE-TRIAL PNET HR+5
Dufour, C.
Delisle, M. B.
Geoffray, A.
Laplanche, A.
Frappaz, D.
Icher, C.
Bertozzi, A. I.
Leblond, P.
Doz, F.
Andre, N.
DeCarli, E.
Schneider, P.
Berger, C.
Lejars, O.
Chastagner, P.
Pagnier, A.
Soler, C.
Werle, N. Entz
Couanet, D. Valteau
PEDIATRIC BLOOD & CANCER, 2014, 61 : S111 - S111
[10] Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study
F Lefrère
A Delmer
F Suzan
V Levy
C Belanger
M Djabarri
B Arnulf
G Damaj
N Maillard
V Ribrag
M Janvier
C Sebban
R-O Casasnovas
R Bouabdallah
F Dreyfus
V Verkarre
E Delabesse
F Valensi
E McIntyre
N Brousse
B Varet
O Hermine
Leukemia, 2002, 16 : 587 - 593

← 1 2 →